Cortendo AB: Cortendo and Antisense Therapeutics Announce Licensing Agreement...
GOTEBORG, Sweden & TREVOSE, Pa. & VICTORIA, Australia Cortendo AB (publ) [ticker: CORT on NOTC-A], a biopharmaceutical company focused on rare endocrine disorders and other rare diseases,...
View ArticleOMT Therapeutics Announces UniRat™ Alliance with Caltech
PALO ALTO, Calif. OMT Therapeutics, Inc. (OMT Therapeutics) today announced a partnership with the California Institute of Technology (Caltech) under which Caltech will use OMT Therapeutics’ fully...
View ArticleMacrogen Enters Exome Sequencing Analysis Service Provision Agreement with...
SEOUL, South Korea The personalized medicine and biotechnology company, Macrogen (CEO Hyonyong Chong, www.macrogen.com) (KOSDAQ:038290) has announced that the company has entered into a genome...
View ArticleOTSUKA’S JINARC® THE FIRST-EVER TREATMENT APPROVED IN EUROPE FOR ADULTS...
TOKYO Otsuka Pharmaceutical Co., Ltd. announced today that the European Commission has granted marketing authorisation for JINARC® (tolvaptan) for the treatment of ADPKD in adults who have chronic...
View ArticleSysmex and LabCorp Announce a Strategic Collaboration for Blood-Based...
KOBE, Japan & BURLINGTON, N.C. Sysmex Corporation (TSE:6869) and Laboratory Corporation of America® Holdings (LabCorp®) (LH:NYSE) today announced a strategic collaboration focused on the...
View ArticleBioCision to Develop Customized ThawSTAR Automated Cell Thawing System for...
SAN RAFAEL, Calif. BioCision, LLC, a leader in advanced technology to improve biological sample handling and standardization, today announced that it will collaborate with Celgene Cellular...
View ArticleDNAnexus Powers Research and Analysis of Rice Genomes to Help Feed World’s...
MOUNTAIN VIEW, Calif. DNAnexus Inc. announced today that its groundbreaking cloud-based genome informatics and data management platform is powering the 3000 Rice Genomes Project (3K RGP). The...
View ArticleAllele Biotechnology & Pharmaceuticals Closes Purchase of cGMP Facility for...
SAN DIEGO Allele Biotechnology & Pharmaceuticals, Inc. (“Allele”), a leader in the development of specialized cells for pharmaceutical drug discovery and regenerative medicine, today announced...
View ArticleAllele Biotechnology & Pharmaceuticals完成对cGMP设施的收购,用于生产面向细胞疗法应用的临床级细胞
圣迭戈 (美国商业资讯) — Allele Biotechnology & Pharmaceuticals, Inc. (“Allele”)是开发面向药品发现和再生医学的专用细胞的领先者,该公司今天宣布已完成对一处新设施的收购,用于其按现行药品生产质量管理规范(cGMP)生产面向细胞疗法应用的临床级细胞。...
View ArticleAnnoroad and Illumina to Co-Develop NGS Diagnostic System for Reproductive...
BEIJING & SAN DIEGO Annoroad and Illumina, Inc. (NASDAQ: ILMN) today announced they have entered into an agreement to jointly develop advanced clinical applications for reproductive health based...
View ArticleWaters Welcomes Chang Gung University as Taiwan’s First Centers of Innovation...
MILFORD, Mass. At a recent ceremony at Taipei’s Chang Gung University (CGU), Waters Corporation welcomed the University’s Healthy Aging Research Center as a Waters Centers of Innovation (COI)...
View ArticleOpen Monoclonal Technology Announces OmniAb Alliance With Amgen
PALO ALTO, Calif. Open Monoclonal Technology, Inc. (OMT) today announced a license that provides Amgen Inc. with access to OMT’s proprietary OmniRat®, OmniMouse® and OmniFlic™ human antibody...
View ArticleBIOTEC and Thermo Fisher Scientific to Collaborate on Study of Natural...
SAN JOSE, Calif. & BANGKOK Thermo Fisher Scientific, Inc., the world leader in serving science, and National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and...
View ArticleArcadia Biosciences与Phytola合作提高大豆的油含量
美国加州戴维斯和加拿大阿尔伯塔省埃德蒙顿 (美国商业资讯)–农业生物技术公司Arcadia Biosciences, Inc. (NASDAQ: RKDA)宣布与油籽作物研究的领先者Phytola合作,开发油含量更高的大豆变种。该研发项目近期获得来自于Genome Canada的经费。 该项目基于Phytola科学总监Randall...
View Article位于圣地亚哥的Allele Biotechnology & Pharmaceuticals 购置个人干细胞储存中心设施,启动临床水平多功能干细胞生产
圣地亚哥 (美国商业资讯) — Allele Biotechnology & Pharmaceuticals, Inc. (“Allele”)近日宣布了正式进入临床级细胞生产领域。 Allele将利用其专利合成mRNA生产人类诱导多能干细胞(hiPSCs)的技术生产以细胞治疗为目的的hiPSCs。2015年3月美国在纳斯达克上市的Ocata Therapeutics(前名为ACT,...
View ArticleJapanese Biotech JCR Pharmaceuticals Selects Medidata’s Cloud-Based Platform...
NEW YORK Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that its cloud-based technology platform has been...
View ArticleBiogen and Sobi Announce European Medicines Agency Validates ALPROLIX®...
CAMBRIDGE, Mass. & STOCKHOLM Biogen (NASDAQ: BIIB) and Swedish Orphan Biovitrum AB (publ) (Sobi) (STO: SOBI) today announced that the European Medicines Agency (EMA) has accepted the Marketing...
View ArticleStemgent, a ReproCELL Group Company Launches a New High Performance...
YOKOHAMA, Japan We are pleased to announce that Stemgent Inc. (Cambridge, MA), a ReproCELL Group Company (Yokohama, Japan – JASDAQ: 4978) has launched its new Stemgent StemRNA™-SR Reprogramming Kit,...
View ArticleOvercoming Challenges in Sequence Analysis of FFPE Tissue Due to...
BOLOGNA, Italy Silicon Biosystems, a Bologna (Italy) and San Diego (CA, USA) based biotech company that is part of the pharmaceutical Menarini Group, presented recent findings obtained with its...
View Article